PROTECT Trial: Protecting nursing home residents from infections and readmissions
PROTECT Trial: Protecting nursing home residents from infections and readmissions
批准号:
9007823
负责人:
Susan S. Huang
金额:
$232.86万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-30 至 2020-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The 3 million Americans in U.S. nursing homes experience a staggering 2-3 million healthcare- associated infections each year. These infections result in over 150,000 readmissions and over 380,000 deaths annually. Nursing homes care for persons at high risk for infection due to the high prevalence of older age, wounds, medical devices, and comorbidities. Nursing homes also admit many residents that harbor multi- drug resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant enterococci (VRE), and emerging pan-resistant gram negative rods that cause serious and deadly disease. These pathogens carry associated risks for transmission among nursing home residents. Contact precautions and isolation, the mainstays of infection control in hospitals, do not provide a practical solution for nursing homes where socialization and a home-like environment are key components of recovery and quality of life. Decolonization strategies may provide a simple and low-cost solution to prevent infection and readmissions by reducing body surface bacteria that can cause infection. Our investigative team recently evaluated the effect of decolonization in a large pragmatic cluster- randomized clinical trial in hospital intensive care units and found that topical decolonization with antiseptc soap and nasal ointments reduced the burden of multi-drug resistant bacteria by over one-third and reduced bloodstream infections by nearly one-half. We will build on this experience to tailor a decolonization protocol to nursing home routines. We will test the hypothesis that decolonization might protect nursing home residents from infection and hospital readmission. We will also evaluate its potential benefit in decreasing the bioburden of multi-drug resistant organisms. The PROTECT Trial will rely upon a multi-disciplinary team of researchers with expertise in infectious diseases, infection prevention, geriatrics, nursing home care and administration, nursing education, and biostatistics to conduct a large cluster-randomized trial of
decolonization in nursing homes that has the potential to decrease the substantial morbidity due to healthcare-associated infections in this vulnerable population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10549488
-
项目类别:
-
资助金额:$19.91万
-
财政年份:2023
-
负责人:Susan S. Huang
-
依托单位:
MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes
-
批准号:10549487
-
项目类别:
-
资助金额:$285.31万
-
财政年份:2023
-
负责人:Susan S. Huang
-
依托单位:
Epidemiology of MDRO Carriage in Nursing Homes
-
批准号:10549490
-
项目类别:
-
资助金额:$132.71万
-
财政年份:2023
-
负责人:Susan S. Huang
-
依托单位:
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)
-
批准号:10501944
-
项目类别:
-
资助金额:$49.48万
-
财政年份:2022
-
负责人:Susan S. Huang
-
依托单位:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
-
批准号:10198711
-
项目类别:
-
资助金额:$157.4万
-
财政年份:2020
-
负责人:Susan S. Huang
-
依托单位:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
-
批准号:10018193
-
项目类别:
-
资助金额:$164.65万
-
财政年份:2020
-
负责人:Susan S. Huang
-
依托单位:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
-
批准号:10631986
-
项目类别:
-
资助金额:$153.68万
-
财政年份:2020
-
负责人:Susan S. Huang
-
依托单位:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
-
批准号:10418669
-
项目类别:
-
资助金额:$155.07万
-
财政年份:2020
-
负责人:Susan S. Huang
-
依托单位:
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention COVID-19 Supplement
-
批准号:10192605
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2016
-
负责人:Susan S. Huang
-
依托单位:
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention
-
批准号:9305764
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2016
-
负责人:Susan S. Huang
-
依托单位:
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention
-
批准号:9206710
-
项目类别:
-
资助金额:$520.0万
-
财政年份:2016
-
负责人:Susan S. Huang
-
依托单位:
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
-
批准号:9043018
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2015
-
负责人:Susan S. Huang
-
依托单位:
The SAFER Lines Project: Standardizing Assessment For Effective Response
-
批准号:9060012
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2015
-
负责人:Susan S. Huang
-
依托单位:
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
-
批准号:8850167
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2014
-
负责人:Susan S. Huang
-
依托单位:
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
-
批准号:8654015
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:Susan S. Huang
-
依托单位:
DECREASING BIOBURDEN TO REDUCE HEALTHCARE-ASSOCIATED INFECTIONS AND READMISSIONS
-
批准号:8719445
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2012
-
负责人:Susan S. Huang
-
依托单位:
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions
-
批准号:9197951
-
项目类别:
-
资助金额:$144.44万
-
财政年份:2012
-
负责人:Susan S. Huang
-
依托单位:
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions
-
批准号:8788802
-
项目类别:
-
资助金额:$149.93万
-
财政年份:2012
-
负责人:Susan S. Huang
-
依托单位:
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions
-
批准号:8774999
-
项目类别:
-
资助金额:$178.08万
-
财政年份:2012
-
负责人:Susan S. Huang
-
依托单位:
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions
-
批准号:8465162
-
项目类别:
-
资助金额:$81.05万
-
财政年份:2012
-
负责人:Susan S. Huang
-
依托单位:
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
-
批准号:81973152
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2019
-
负责人:胡东生
-
依托单位: